Education
About Us
Working with TipRanks
Follow Us
Karen Prange Insider Profile
11 Followers
Karen Prange, SVP&Pres, Uro & Pelvic Health at Boston Scientific, holds 17.83K shares in Atricure (Ticker: ATRC), holds 39.74K shares in Embecta Corporation (Ticker: EMBC), holds 33.95K shares in Nevro Corp (Ticker: NVRO). Most recently, Karen Prange Sold ― shares of Atricure on Mar 07, 2025 for an estimated value of 232.53K.
Karen Prange Boston Scientific (BSX)SVP&Pres, Uro & Pelvic Health
Boston Scientific (BSX)
SVP&Pres, Uro & Pelvic Health
Ranked #76,332 out of 100,956 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-19.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Karen Prange holds in companies
Most Profitable Insider Trade
The most profitable trade made by Karen Prange
Karen Prange's Trading History
Boston Scientific
Mar 08, 2016
SVP&Pres, Uro & Pelvic Health
Uninformative Sell
254.68K
$5.37M
Henry Schein
Mar 06, 2018
EVP&CEO Gl.AH.Med.Den.Sur.Grp
Uninformative Buy
―
$4.69M
Atricure
Mar 07, 2025
Director
Informative Sell
232.53K
$615.42K
Nevro Corp
May 28, 2024
Director
Uninformative Buy
―
$195.88K
Cantel Medical
Jul 31, 2020
―
Uninformative Buy
―
$155.52K
Viewray
Jul 21, 2023
Director
Informative Sell
8.31K
$105.59
Embecta Corporation
Feb 14, 2025
Director
Uninformative Buy
―
$506.72K
List of latest transactions for each holding click on a transaction to see Karen Prange's performance on stock
You May Also Like
Karen Prange insider profile FAQ
What is the percentage of profitable transactions made by Karen Prange?
The percentage of profitable transactions made by Karen Prange is 25%.
What is the average return per transaction made by Karen Prange?
The average return per transaction made by Karen Prange is -19.30%.
What stocks does Karen Prange hold?
Karen Prange holds: BSX, HSIC, ATRC, NVRO, CMD, VRAYQ, EMBC stocks.
What was Karen Prange’s latest transaction?
Karen Prange latest transaction was an Informative Sell of $232.53K.
What was Karen Prange's most profitable transaction?
Karen Prange’s most profitable transaction was an Informative Sell of ATRC stock on June 12, 2023. The return on the trade was 53.20%.
What is Karen Prange's role in Boston Scientific?
Karen Prange's role in Boston Scientific is SVP&Pres, Uro & Pelvic Health.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.